Histiocytosis - 48 Studies Found
Terminated |
: Unrelated Donor Transplant for Malignant and Non-Malignant Disorders :
: |
Terminated |
: Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer :
|
Terminated |
: Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases :
: |
Terminated |
: Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer :
|
Recruiting |
: New Candidate Criteria for Diagnosis of Macrophage Activation Syndrome :
|
RECRUITING |
: Mirdametinib in Histiocytic Disorders : Langerhans Cell Histiocytosis (LCH) : 2024-11-21 : Mirdametinib is administered at a dose of 2 mg/m2, twice a day (BID) with a maximum dose of 4 mg BID on a continuous daily schedule.Consecu |
RECRUITING |
: LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study : Langerhans Cell Histiocytosis : 2024-11-21 : Diagnostic and therapeutic data of adult patients with LCH, collected from clinical and laboratory evaluations, carried out during clinical practice. |